Journal of Inherited Metabolic Disease

, Volume 13, Issue 4, pp 523–537

Disorders of glycoprotein degradation

  • M. Cantz
  • B. Ulrich-Bott
Article

Summary

The intracellular degradation of glycoproteins occurs predominantly in the lysosomes through the concerted action of proteases and glycosidases. Genetic defects in any of the enzymes cleaving the oligosaccharide side chains lead to specific diseases because of an excessive lysosomal accumulation of partially degraded material, mostly oligosaccharides.

This paper presents an overview of the biochemistry and the clinical spectrum of this group of diseases including sialidosis, galactosialidosis,α-andβ-mannosidosis, fucosidosis, aspartylglucosaminuria, andα-N-acetylgalactosaminidase deficiency (Schindler disease). In addition, the sialic acid storage disorder (Salla disease) which is caused by a defect in the lysosomal transport of this acidic monosaccharide is included because of functional and clinical correlations.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aula, P., Autio, S., Raivio, K. O., Rapola, J., Thoden, C.-J., Koskela, S.-L. and Yamashina, J. ‘Salla disease’, a new lysosomal storage disorder.Arch. Neurol. 36 (1979) 88–94Google Scholar
  2. Aula, P., Autio, S., Raivio, K. O. and Rapola, J. Aspartylglucosaminuria. In Durand, P. and O'Brien, J. S. (eds.),Genetic Errors of Glycoprotein Metabolism, edi ermes, Milano, Springer-Verlag, Berlin, Heidelberg, New York, 1982, pp. 123–152Google Scholar
  3. Baumkötter, J., Cantz, M., Mendla, K., Baumann, W., Friebolin, H., Gehler, J. and Spranger, J. N-Acetylneuraminic acid storage disease.Hum. Genet. 71 (1985) 155–159Google Scholar
  4. Beaudet, A. L. and Thomas, G. H. Disorders of glycoprotein degradation: mannosidosis, fucosidosis, sialidosis, and aspartylglycosaminuria. In Scriver, C. R., Beaudet, A. L., Sly, W. S. and Valle, D. (eds.),The Metabolic Basis of Inherited Disease, 6th edn., McGraw-Hill, New York, 1989, pp. 1603–1621Google Scholar
  5. Berger, E. G., Buddecke, E., Kamerling, J. P., Kobata, A., Paulson, J. C. and Vliegenthart, J. F. G. Structure, biosynthesis and functions of glycoprotein glycans.Experientia 38 (1982) 1129–1258Google Scholar
  6. Cantz, M. and Messer, H. Oligosaccharide and ganglioside neuraminidase activities of mucolipidosis I (sialidosis) and mucolipidosis II (I-cell disease) fibroblasts.Eur. J. Biochem. 97 (1979) 113–118Google Scholar
  7. Cantz, M., Gehler, J. and Spranger, J. Mucolipidosis I: increased sialic acid content and deficiency of anα-N-acetylneuraminidase in cultured fibroblasts.Biochem. Biophys. Res. Commun. 74 (1977) 732–738Google Scholar
  8. Chester, M. A., Lundblad, A., Öckerman, P. A. and Autio, S. Mannosidosis. In Durand, P. and O'Brien, J. S. (eds.),Genetic Errors of Glycoprotein Metabolism, edi ermes, Milano, Springer-Verlag, Berlin, Heidelberg, New York, 1982, pp. 89–122Google Scholar
  9. Cooper, A., Sardharwalla, I. B. and Roberts, M. M. Humanβ-mannosidase deficiency.N. Engl. J. Med. 315 (1986) 1231Google Scholar
  10. D'Azzo, A., Hoogeveen, A., Reuser, A. J. J., Robinson, D. and Galjaard, H. Molecular defect in combinedβ-galactosidase and neuraminidase deficiency in man.Proc. Natl. Acad. Sci. USA 79 (1982) 4535–4539Google Scholar
  11. De Gasperi, R., Li, Y.-T. and Li, S.-C. Presence of two endo-β-N-acetylglucosaminidases in human kidney.J. Biol. Chem. 264 (1989) 9329–9334Google Scholar
  12. Dorland, L., Duran, M., Hoefnagels, F. E. T., Breg, J. N., Fabery de Jonge, H., Cransberg, K., van Sprang, F. J. and van Diggelen, O. P.β-Mannosidosis in two brothers with hearing loss.J. Inher. Metab. Dis. 11, Suppl. 2 (1988) 255–258Google Scholar
  13. Durand, P. and O'Brien, J. S. (eds.),Genetic Errors of Glycoprotein Metabolism, edi ermes, Milano, Springer-Verlag, Berlin, Heidelberg, New York, 1982Google Scholar
  14. Durand, P., Gatti, R., Cavalieri, S., Borrone, C., Tondeur, M., Michalski, J.-C. and Strecker, G. Sialidosis (mucolipidosis I).Helv. Paediatr. Acta 32 (1977) 391–400Google Scholar
  15. Durand, P., Gatti, R. and Borrone, C. Fucosidosis. In Durand, P. and O'Brien, J. S. (eds.),Genetic Errors of Glycoprotein Metabolism, edi ermes, Milano, Springer-Verlag, Berlin, Heidelberg, New York, 1982, pp. 49–87Google Scholar
  16. Gahl, W. A., Renlund, M. and Thoene, J. G. Lysosomal transport disorders: Cystinosis and sialic acid storage disorders. In Scriver, C. R., Beaudet, A. L., Sly, W. S. and Valle, D. (eds.),The Metabolic Basis of Inherited Disease, 6th edn., McGraw-Hill, New York, 1989, pp. 2619–2647Google Scholar
  17. Galjaard, H., Willemsen, R., Hogeveen, A. T., Mancini, G. M. S., Palmeri, S., Verheijen, F. W. and D'Azzo, A. Molecular heterogeneity in humanβ-galactosidase and neuraminidase deficiency.Enzyme 38 (1987) 132–143Google Scholar
  18. Galjart, N. J., Gillemans, N., Harris, A., van der Horst, G. T. J., Verheijen, F. W., Galjaard, H. and D'Azzo, A. Expression of cDNA encoding the human ‘protective protein’ associated with lysosomalβ-galactosidase and neuraminidase: homology to yeast proteases.Cell 54 (1988) 755–764Google Scholar
  19. Harzer, K., Cantz, M., Sewell, A. C., Dhareshwar, S. S., Roggendorf, W., Heckl, R. W., Schofer, O., Thumler, R., Peiffer, J. and Schlote, W. Normomorphic sialidosis in two female adults with severe neurologic disease and without sialyl oligosacchariduria.Hum. Genet. 74 (1986) 209–214Google Scholar
  20. Johnson, K. and Dawson, G. Molecular defect in processingα-fucosidase in fucosidosis.Biochem. Biophys. Res. Commun. 133 (1985) 90Google Scholar
  21. Jones, M. Z. and Dawson, G. Caprineβ-mannosidosis. Inherited deficiency ofβ-d-mannosidase.J. Biol. Chem. 256 (1981) 5185–5188Google Scholar
  22. Kelly, T. E. and Graetz, G. Isolated acid neuraminidase deficiency: a distinct lysosomal storage disease.Am. J. Med. Genet. 1 (1977) 31–46Google Scholar
  23. Kuranda, M. J. and Aronson, N. N. Use of active site-directed inhibitors to studyin situ degradation of glycoproteins by the perfused rat liver.J. Biol. Chem. 260 (1985) 1856–1866Google Scholar
  24. Lieser, M., Harms, E., Kern, H., Bach, G. and Cantz, M. Ganglioside GM3 sialidase activity in fibroblasts of normal individuals and of patients with sialidosis and mucolipidosis IV. Subcellular distribution and some properties.Biochem. J. 260 (1989) 69–74Google Scholar
  25. Lowden, J. A. and O'Brien, J. S. Sialidosis: A review of human neuraminidase deficiency.Am. J. Hum. Genet. 31 (1979) 1–18Google Scholar
  26. Mendla, K., Baumkötter, J., Rosenau, C., Ulrich-Bott, B. and Cantz, M. Defective lysosomal release of glycoprotein-derived sialic acid in fibroblasts from patients with sialic acid storage disease.Biochem. J. 250 (1988) 261–267Google Scholar
  27. O'Brien, J. S. Neuraminidase deficiency in the cherry-red spot-myoclonus syndrome.Biochem. Biophys. Res. Commun. 79 (1977) 1163–1241Google Scholar
  28. O'Brien, J. S. Sialidosis. In Durand, P. and O'Brien, J. S. (eds.),Genetic Errors of Glycoprotein Metabolism, edi ermes, Milano, Springer-Verlag, Berlin, Heidelberg, New York, 1982, pp. 33–48Google Scholar
  29. O'Brien, J. S.β-Galactosidase deficiency (GM1 gangliosidosis, galactosialidosis, and Morquio syndrome type B); ganglioside sialidase deficiency (mucolipidosis IV). In Scriver, C. R., Beaudet, A. L., Sly, W. S. and Valle, D. (eds.),The Metabolic Basis of Inherited Disease, 6th edn., McGraw-Hill, New York, 1989, pp. 1797–1806Google Scholar
  30. Öckerman, P.-A. A generalized storage disorder resembling Hurler's syndrome.Lancet 2 (1967) 239–241Google Scholar
  31. Pollitt, R. J., Jenner, F. A. and Merskey, H. Aspartylglycosaminuria: an inborn error of metabolism associated with mental defect.Lancet 2 (1968) 253Google Scholar
  32. Rapin, I., Goldfischer, S., Katzman, R., Engel, J. and O'Brien, J. S. The cherry-red spotmyoclonus syndrome.Ann. Neurol. 3 (1978) 234–242Google Scholar
  33. Schindler, D., Bishop, D. F., Wolfe, D. E., Wang, A. M., Egge, H., Lemieux, R. U. and Desnick, R. J. Neuroaxonal dystrophy due to lysosomalα-N-acetylgalactosaminidase deficiency.N. Engl. J. Med. 320 (1989) 1735–1740Google Scholar
  34. Strecker, G., Peers, M. C., Michalski, J. C., Hondi-Assah, T., Fournet, B., Spik, G., Montreuil, J., Farriaux, J. P., Marteaux, P. and Duran, P. Structure of nine sialyloligosaccharides accumulated in nine of eleven patients with three different types of sialidosis.Eur. J. Biochem. 75 (1977) 391–398Google Scholar
  35. Thomas, G. H., Tipton, R. E., Chien, L. T., Reynolds, L. W. and Miller, C. S. Sialidase (α-N-acetylneuraminidase) deficiency: the enzyme defect in an adult with macular cherry-red spots and myoclonus without dementia.Clin. Genet. 13 (1978) 369–379Google Scholar
  36. Ulrich-Bott, B., Klem, B., Kaiser, R., Spranger, J. and Cantz, M. Lysosomal sialidase deficiency: increased ganglioside content in autopsy tissues of a sialidosis patient.Enzyme 38 (1987) 262–266Google Scholar
  37. Vamos, E., Libert, J., Elkhazen, N., Jauniaux, E., Hustin, J., Wilkin, P., Baumkötter, J., Mendla, K. and Cantz, M. Prenatal diagnosis and confirmation of infantile sialic acid storage disease.Prenat. Diagn. 6 (1986) 437–446Google Scholar
  38. van Diggelen, O. P., Schindler, D., Willemsen, R., Boer, M., Kleijer, W. J., Huijmans, G. M., Blom, W. and Galjaard, H.α-N-acetylgalactosaminidase deficiency, a new lysosomal storage disorder.J. Inher. Metab. Dis. 11 (1988) 349–357Google Scholar

Copyright information

© SSIEM and Kluwer Academic Publishers 1990

Authors and Affiliations

  • M. Cantz
    • 1
  • B. Ulrich-Bott
    • 1
  1. 1.Institute of Pathochemistry and General NeurochemistryUniversity of HeidelbergHeidelbergFRG

Personalised recommendations